TheWell Bioscience supports scientists and researchers by offering a novel 3D cell culture hydrogel system for drug screening, tissue engineering, and pre-clinical applications.
TheWell Bioscience’s xeno-free 3D hydrogel platform (VitroGel™) has solved the issues of current animal-derived ECM system by providing better consistency and capability beyond laboratory applications. The system is room temperature stable and ready-to-use, shortening the 3D cell culture operation time from a few hours to 20 minutes with one simple mixing step. Such uniqueness of this hydrogel platform allows the matrix-based 3D cell culture research to be adapted for laboratory automation and high throughput screening.
By helping scientists generate more accurate data with higher efficiency, TheWell Bioscience aims to accelerate the process of drug discovery and personalized medicine by filling the gap between traditional 2D studies and animal model with a robust 3D model analysis platform.